#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12816	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2063	612.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	776	C	762	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	688.4	0	.	n	.	0	T695C	SNP	695	695	T	1047	1047	C	709	C	700	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	688.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1689	1689	A	810	A,G	789,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	688.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2323	2323	C	727	C	713	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	688.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2397	2397	A	746	A,G	729,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	688.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2949	2949	C	731	C,A,T	717,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	V36A	NONSYN	106	108	GTG	374	376	GCG	192;190;190	G;C;G	187;186;184	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	416	418	CGG	197;197;196	C;G;G	193;192;192	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	S68L	NONSYN	202	204	TCG	470	472	TTG	177;175;176	T,C;T,C;G	164,2;172,2;167	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	A90V	NONSYN	268	270	GCG	536	538	GTT	171;172;172	G;T,C;T,G	169;160,1;167,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	I105V	NONSYN	313	315	ATT	581	583	GTT	152;151;150	G;T;T	152;141;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	N125T	NONSYN	373	375	AAT	641	643	ACC	143;142;144	A;C;C	138;140;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	R135C	NONSYN	403	405	CGT	671	673	TGT	136;136;135	T,C;G;T,C	117,1;132;119,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	K151E	NONSYN	451	453	AAA	719	721	GAA	110;109;107	G;A;A	107;108;106	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	722	724	AAC	106;107;107	A;A;C	106;105;106	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	A172T	NONSYN	514	516	GCG	782	784	ACA	108;107;108	A;C;A	102;105;104	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	A175E	NONSYN	523	525	GCG	791	793	GAA	108;108;110	G;A;A	105;107;107	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	E176T	NONSYN	526	528	GAA	794	796	ACC	110;111;111	A;C;C	102;110;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	I178V	NONSYN	532	534	ATC	800	802	GTC	113;112;111	G;T;C	110;110;110	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	I188T	NONSYN	562	564	ATA	830	832	ACG	126;128;127	A;C;G	119;124;124	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	P200N	NONSYN	598	600	CCC	866	868	AAC	126;128;130	A;A;C	122;121;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	F220L	NONSYN	658	660	TTT	926	928	TTG	144;145;147	T;T,G;G	139;140,1;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	A239T	NONSYN	715	717	GCA	983	985	ACC	118;119;120	A;C;C	113;116;117	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	N240D	NONSYN	718	720	AAT	986	988	GAC	119;120;122	G;A,G;C	116;114,1;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	E243A	NONSYN	727	729	GAA	995	997	GCG	123;122;124	G;C,A;G	121;90,1;121	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1031	1033	GCT	106;106;107	G;C,G;T	104;97,1;98	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1566	folP	858	858	91.61	folP.l6.c17.ctg.1	1425	108.4	1	SNP	p	R230S	1	.	.	688	690	AGC	956	958	AGC	147;148;148	A;G;C	140;140;141	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	141.3	1	SNP	p	S91F	0	.	.	271	273	TCC	623	625	TCC	166;169;168	T;C;C	163;167;164	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	141.3	1	SNP	p	D95N	0	.	.	283	285	GAC	635	637	GAC	168;168;167	G;A;C	166;159;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	141.3	1	SNP	p	D95G	0	.	.	283	285	GAC	635	637	GAC	168;168;167	G;A;C	166;159;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1730	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1377	124.2	1	SNP	p	G45D	1	.	.	133	135	GAC	501	503	GAC	196;200;200	G;A,G;C,A	190;190,1;191,1	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	924	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	957	94.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3197	134.7	1	SNP	p	D86N	0	.	.	256	258	GAC	652	654	GAC	181;180;180	G,A;A;C	174,1;172;175	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3197	134.7	1	SNP	p	S87R	0	.	.	259	261	AGT	655	657	AGT	181;183;183	A;G;T	179;180;173	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3197	134.7	1	SNP	p	S87I	0	.	.	259	261	AGT	655	657	AGT	181;183;183	A;G;T	179;180;173	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3197	134.7	1	SNP	p	S87W	0	.	.	259	261	AGT	655	657	AGT	181;183;183	A;G;T	179;180;173	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3197	134.7	1	SNP	p	S88P	0	.	.	262	264	TCC	658	660	TCC	181;182;183	T;C;C	178;177;181	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3836	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2608	145.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	178;179;176	G;G;C	172;173;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1297	1299	GCC	197;196;198	G;C;C	192;193;192	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1300	1302	ATG	199;199;198	A;T;G	193;194;192	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1312	1314	ACC	191;191;188	A;C;C	184;186;183	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1312	1314	ACC	191;191;188	A;C;C	184;186;183	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1813	1815	ACC	186;186;186	A;C;C	175;183;183	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1867	1869	GCG	186;192;194	G;C;G	183;188;189	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1867	1869	GCG	186;192;194	G;C;G	183;188;189	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1990	1992	GGT	146;146;144	G;G;T	142;140;138	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1999	2001	AGC	142;141;139	A;G;C	133;135;129	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2469	141.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2017	2019	CCG	121;123;123	C,G;C,G;G,C	113,1;112,1;104,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5176	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3114	164.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1682	1684	CTG	162;160;158	C;T;G	155;151;149	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2298	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1764	128.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	582	582	C	161	C,G	152,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	76	78	AAT	16;17;16	A;A;T	14;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	79	81	AAT	16;16;16	A;A;T	15;15;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	103	105	GCA	16;16;17	G;C;A	16;16;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	126	128	GTA	15;16;15	G;T;A	15;16;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	S236N	NONSYN	706	708	AGC	132	134	AAC	15;15;15	A;A;C,A	15;15;14,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	N237M	NONSYN	709	711	AAC	135	137	ATG	15;15;15	A;T;G	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	297	90.7	porB1a.l6.c30.ctg.1	353	25.8	0	.	p	.	0	D238fs	FSHIFT	712	712	G	138	138	G	15	G	14	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1650	144.9	0	.	p	.	0	E41K	NONSYN	121	123	GAA	499	501	AAA	173;173;172	A;A;A	168;170;169	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1650	144.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1009	1009	T	199	T,A	190,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1650	144.9	1	SNP	p	G120K	0	.	.	358	360	GGT	736	738	GGT	194;193;190	G;G;T	188;189;179	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1650	144.9	1	SNP	p	A121D	0	.	.	361	363	GCC	739	741	GCC	192;192;194	G;C;C	187;185;188	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1650	144.9	1	SNP	p	A121N	0	.	.	361	363	GCC	739	741	GCC	192;192;194	G;C;C	187;185;188	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8368	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4927	168.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2113	2115	CAT	186;183;182	C;A;T	182;181;178	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	990	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1183	82.5	1	SNP	p	V57M	1	.	.	169	171	ATG	616	618	ATG	190;195;195	A;T;G	190;193;194	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
